Skip NavigationSkip to Content

TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cells

  1. Author:
    Poehlein, C. H.
    Hu, H. M.
    Yamada, J.
    Assmann, K.
    Alvord, W. G.
    Urba, W. J.
    Fox, B. A.
  2. Author Address

    Providence Portland Med Ctr, Earle A Chiles Res Inst, Robert W Franz Canc Res Ctr, Lab Mol & Tumor Immunol, 4805 NE Gilsan St, Portland, OR 97213 USA Providence Portland Med Ctr, Earle A Chiles Res Inst, Robert W Franz Canc Res Ctr, Lab Mol & Tumor Immunol, Portland, OR 97213 USA Providence Portland Med Ctr, Earle A Chiles Res Inst, Robert W Franz Canc Res Ctr, Lab Clin Res, Portland, OR 97213 USA Oregon Hlth & Sci Univ, Oregon Grad Inst, Dept Biochem & Mol Biol, Portland, OR 97202 USA Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97202 USA Oregon Hlth & Sci Univ, Oregon Canc Ctr, Portland, OR 97202 USA NCI, Frederick Canc Res & Dev Ctr, Data Management Serv, Frederick, MD 21702 USA Fox BA Providence Portland Med Ctr, Earle A Chiles Res Inst, Robert W Franz Canc Res Ctr, Lab Mol & Tumor Immunol, 4805 NE Gilsan St, Portland, OR 97213 USA
    1. Year: 2003
  1. Journal: Journal of Immunology
    1. 170
    2. 4
    3. Pages: 2004-2013
  2. Type of Article: Article
  1. Abstract:

    We have recently shown that effector T cells (T-E) lacking either perforin or IFN-gamma are highly effective mediators of tumor regression. To rule out compensation by either mechanism, TE deficient in both perforin and IFN-gamma (perforin knockout (PKO)/IFN-gamma knockout (GKO)) were generated. The adoptive transfer of PKO/GKO T, mediated complete tumor regression and cured wild-type animals with established pulmonary metastases of the B16BL6-D5 (D5) melanoma cell line. PKO/GKO T-E also mediated tumor regression in D5 tumor-bearing PKO, GKO, or PKO/GKO recipients, although in PKO/GKO recipients efficacy was reduced. PKO/GKO T-E exhibited tumor-specific TNF-alpha production and cytotoxicity in a 24-h assay, which was blocked by the soluble TNFRII-human IgG fusion protein (TNFRII:Fc). Blocking TNF in vivo by administering soluble TNFR 11 fusion protein (TNFRII:Fc) significantly reduced the therapeutic efficacy of PKO/GKO, but not wild-type T-E. This study identifies perforin, IFN-gamma and TNF as a critical triad of effector molecules that characterize therapeutic antitumor T cells. These insights could be used to monitor and potentially tune the immune response to cancer vaccines.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel